海吉亚医疗降目标价至15.9港元，维持“跑赢大市”评级

里昂证券02-04

一、里昂证券调整海吉亚医疗目标价及评级里昂证券发布研报，对海吉亚医疗(06078)的未来表现进行分析。尽管将其目标价从17港元下调至15.9港元，但仍维持“跑赢大市”的投资评级。该行认为，展望2026年，公司主要的增长动力将来自非国家医保目录收入的扩张、现有医院利用率的提升以及通过降低负债率推动经营杠杆以重建利润率。二、盈警后业绩下滑或已触底虽然海吉亚医疗近期发布了盈警，但里昂证券认为其业绩下滑...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2608036393?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-04 16:16","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2608036393","market":"hk","top_or_hot":-1,"title":"海吉亚医疗降目标价至15.9港元，维持“跑赢大市”评级","media":"里昂证券","content":"<div>\n<p>一、里昂证券调整海吉亚医疗目标价及评级里昂证券发布研报，对海吉亚医疗(06078)的未来表现进行分析。尽管将其目标价从17港元下调至15.9港元，但仍维持“跑赢大市”的投资评级。该行认为，展望2026年，公司主要的增长动力将来自非国家医保目录收入的扩张、现有医院利用率的提升以及通过降低负债率推动经营杠杆以重建利润率。二、盈警后业绩下滑或已触底虽然海吉亚医疗近期发布了盈警，但里昂证券认为其业绩下滑...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163045a47b092b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>海吉亚医疗降目标价至15.9港元，维持“跑赢大市”评级</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n海吉亚医疗降目标价至15.9港元，维持“跑赢大市”评级\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-04 16:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163045a47b092b&s=b><strong>里昂证券</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>一、里昂证券调整海吉亚医疗目标价及评级里昂证券发布研报，对海吉亚医疗(06078)的未来表现进行分析。尽管将其目标价从17港元下调至15.9港元，但仍维持“跑赢大市”的投资评级。该行认为，展望2026年，公司主要的增长动力将来自非国家医保目录收入的扩张、现有医院利用率的提升以及通过降低负债率推动经营杠杆以重建利润率。二、盈警后业绩下滑或已触底虽然海吉亚医疗近期发布了盈警，但里昂证券认为其业绩下滑...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163045a47b092b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06078","symbol_name":"海吉亚医疗","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163045a47b092b&s=b","article_id":"2608036393","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163045a47b092b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2608036393","pubTimestamp":1770192979,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"尽管将其目标价从17港元下调至15.9港元，但仍维持“跑赢大市”的投资评级。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"06078":"海吉亚医疗"},"translate_title":"Hygeia Medical lowers target price to HK $15.9 and maintains \"outperform\" rating","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06078":1.5},"content_text":"一、里昂证券调整海吉亚医疗目标价及评级里昂证券发布研报，对海吉亚医疗(06078)的未来表现进行分析。尽管将其目标价从17港元下调至15.9港元，但仍维持“跑赢大市”的投资评级。该行认为，展望2026年，公司主要的增长动力将来自非国家医保目录收入的扩张、现有医院利用率的提升以及通过降低负债率推动经营杠杆以重建利润率。二、盈警后业绩下滑或已触底虽然海吉亚医疗近期发布了盈警，但里昂证券认为其业绩下滑已经基本触底。预计下半年营收同比将下降2%至约20亿元人民币，而非国际财务报告准则下的经调整净利润则有望实现3%的正增长。这表明公司在盈利韧性方面有所提升，且经调整净利润趋于稳定，反映出运营执行力正在改善。三、关键增长策略解读里昂证券指出，海吉亚医疗未来的增长重点包括三个方面：一是扩大非国家医保目录收入来源，这有助于减少对单一支付体系的依赖；二是提高现有医院的利用率，从而优化资源分配并增加收益；三是通过降低负债率来改善财务结构，进一步推动经营杠杆效应，最终实现利润率的恢复和提升。四、市场预期与前景展望尽管短期内海吉亚医疗面临一定压力，但里昂证券对其长期发展持乐观态度。公司通过持续优化运营模式和财务状况，有望逐步走出低谷。此外，经调整净利润的稳步回升被视为积极信号，表明管理层在应对挑战时展现出较强的执行能力。这一系列举措或将为投资者带来更稳定的回报。五、结论总体来看，里昂证券虽调低了海吉亚医疗的目标价，但对其未来发展仍保持信心。公司当前正处于调整期，随着关键战略的推进，盈利能力有望逐步修复。对于投资者而言，关注其非医保业务拓展及财务健康状况将是评估其长期价值的重要指标。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2608036393","isCrawlerRequest":true}